Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kotagal, S.
Right arrow Articles by Horenstein, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kotagal, S.
Right arrow Articles by Horenstein, S.
NEUROLOGY 1986;36:438
© 1986 American Academy of Neurology

AB variant GM2 gangliosidosis

Cerebrospinal fluid and neuropathologic characteristics

Suresh Kotagal, MD, David A. Wenger, PhD, Hilda Alcala, MD, Camilo Gomez, MD and Simon Horenstein, MD

Departments of Neurology (Drs. Kotagal, Gomez, and Horenstein) and Pathology (Dr. Alcala), St. Louis University Medical Center, St. Louis, MO; and the Department of Pediatrics (Dr. Wenger), University of Colorado Health Sciences Center, Denver, CO.

A child with AB variant GM2 gangliosidosis who had progressive intellectual deterioration and seizures commencing at the age of 12 months is described. Neuronal loss, and neuronal and astrocytic inclusions characteristic of the gangliosidoses, were seen on cortical biopsy. GM2 ganglioside was detected in the CSF. As CNS ganglioside accumulation in this condition occurs in the presence of normal leukocyte hexosaminidase A and B levels, spinal fluid assay for GM2 ganglioside may serve as a valuable aid in diagnosis.

Address correspondence and reprint requests to Dr. Kotagal, Division of Pediatric Neurology, Department of Neurology, St. Louis University Medical Center, 3660 Vista, St. Louis, MO 63110.

Supported in part by grants from NIH (HD08315 and AM 33170) and a Clinical Research Grant No. 6–413 from the March of Dimes Birth Defects Foundation (DAW).

Presented in part at the thirty-seventh annual meeting of the American Academy of Neurology, Dallas, TX, April 1985.

Accepted for publication July 26, 1985.




This article has been cited by other articles:


Home page
Arch NeurolHome page
D. A. Wenger, S. Coppola, and S.-L. Liu
Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
Arch Neurol, March 1, 2003; 60(3): 322 - 328.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.